Quick Summary:
In an era defining the future of healthcare through evolving technologies, acquiring the latest market insights is paramount. The global real-time PCR, digital PCR, and end-point PCR market is currently standing at a critical juncture witnessing unprecedented growth due to needs in clinical diagnostics, the pharmaceutical industry, and other sectors.
Decision-makers in healthcare and allied sectors must understand that the increasing prevalence of diseases such as lung cancer, blood cancer, and other serious conditions globally are intensifying the demand for advanced diagnostic methodologies. Benefits offered by digital polymerase chain reactions over traditional technologies - such as precise nucleic acid measurements and early diagnosis - are increasingly underpinning their adoption. Meanwhile, upsurges in healthcare expenditures and the essential need for accurate disease detection capabilities in emerging markets present significant opportunities for expansion.
Furthermore, continual technological advancements and a steady rise in product launches are galvanizing the market's evolution. The expanding use of such technologies, alongside heightened R&D activities and collaborations, will invariably accelerate the significance of PCR testing, necessitating astute understanding of current trends and forecasted growth.|
The global real-time PCR, digital PCR, And end-point PCR market size is expected to reach USD 12.91 billion by 2030, registering a CAGR of -11.3%, according to this report. However, the real global real-time PCR, digital PCR, and end-point PCR market without the impact of the COVID-19 pandemic is expected to expand at a compound annual growth rate (CAGR) of 8.7% from 2023 to 2030. Digital PCR is a novel technique for absolute quantification and analysis of minority sequences in the presence of similar majority sequences. dPCR allows for precise and sensitive nucleic acid measurement. In addition, real-time PCR provides precise and early diagnosis of diseases and rapid and targeted patient care hence anticipated to increase the demand in the coming years
The rise in the occurrence of diseases such as lung cancer, blood cancer, and brain tumors is fueling the application expansion of the global market. According to Globocan 2020, lung cancer is the second most common cancer in Europe, with an estimated 477,534 newly diagnosed cases. Furthermore, the benefits of digital polymerase chain reaction over traditional technologies such as real-time and quantitative polymerase chain reaction are likely to drive adoption throughout the forecast period. Moreover, rising healthcare expenditures in emerging nations and the increased need for accurate molecular disease detection are propelling the market growth.
Furthermore, the COVID-19 pandemic has increased the demand for digital PCR instruments and reagents. COVID-19 infections are detected using modern digital PCR instruments as a molecular diagnosis technique. According to the WHO, around 273 million cases have been diagnosed and roughly 5.3 million deaths have been documented worldwide due to COVID-19 as of December 2021. Moreover, in the pharmaceutical industry, digital PCR machines are also employed in R&D.
Furthermore, advancements in technology and an increase in the number of product launches in the global market are expected to support the market growth. For instance, in June 2021, Bio-Rad Laboratories, Inc. announced the release of the PREvalence ddPCR SARS-CoV-2 waste-water quantifying kit for COVID-19 wastewater screening.
Additionally, the increase in R&D projects for advancements in technology and an increase in collaborations between firms for the development of digital polymerase chain reactions are expected to increase the usage of PCR testing. For instance, Qiagen partnered with Atila BioSystems & Actome GmbH in January 2022 to deliver non-invasive prenatal testing (NIPT) technologies to QIAGEN's dPCR for a growing number of applications for QIAcuity. As a result, the usage of real-time and digital PCR technologies is projected to increase during the forecast period.
This product will be delivered within 1-3 business days.
The rise in the occurrence of diseases such as lung cancer, blood cancer, and brain tumors is fueling the application expansion of the global market. According to Globocan 2020, lung cancer is the second most common cancer in Europe, with an estimated 477,534 newly diagnosed cases. Furthermore, the benefits of digital polymerase chain reaction over traditional technologies such as real-time and quantitative polymerase chain reaction are likely to drive adoption throughout the forecast period. Moreover, rising healthcare expenditures in emerging nations and the increased need for accurate molecular disease detection are propelling the market growth.
Furthermore, the COVID-19 pandemic has increased the demand for digital PCR instruments and reagents. COVID-19 infections are detected using modern digital PCR instruments as a molecular diagnosis technique. According to the WHO, around 273 million cases have been diagnosed and roughly 5.3 million deaths have been documented worldwide due to COVID-19 as of December 2021. Moreover, in the pharmaceutical industry, digital PCR machines are also employed in R&D.
Furthermore, advancements in technology and an increase in the number of product launches in the global market are expected to support the market growth. For instance, in June 2021, Bio-Rad Laboratories, Inc. announced the release of the PREvalence ddPCR SARS-CoV-2 waste-water quantifying kit for COVID-19 wastewater screening.
Additionally, the increase in R&D projects for advancements in technology and an increase in collaborations between firms for the development of digital polymerase chain reactions are expected to increase the usage of PCR testing. For instance, Qiagen partnered with Atila BioSystems & Actome GmbH in January 2022 to deliver non-invasive prenatal testing (NIPT) technologies to QIAGEN's dPCR for a growing number of applications for QIAcuity. As a result, the usage of real-time and digital PCR technologies is projected to increase during the forecast period.
Real-time PCR, Digital PCR, And End-point PCR Market Report Highlights
- By technology, the quantitative segment held the largest revenue share in 2022. This is attributed to the high adoption of technology supported by the introduction of products based on real-time polymerase chain reaction for screening and diagnosis of COVID-19
- The consumables and reagents product segment dominated the market in 2022 due to the increased demand for earlier detection and the number of significant companies manufacturing digital PCR consumables and reagents
- North America dominated the global market in 2022 due to the presence of high R&D investment, the availability of a technologically advanced healthcare research framework, the strong presence of prominent polymerase chain reaction manufacturers, and an expanding requirement for rapid diagnostic tests in the region
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1 Methodology and Scope
1.1 Market Segmentation
1.1.1 Product Segment
1.1.2 Technology Segment
1.1.3 Application Segment
1.2 Regional Scope
1.3 Estimates and Forecast Timeline
1.4 Objectives
1.4.1 Objective - 1
1.4.2 Objective - 2
1.4.3 Objective - 3
1.5 Research Methodology
1.6 Information Procurement
1.6.1 Purchased Database
1.6.2 Gvr’s Internal Database
1.6.3 Secondary Sources
1.6.4 Primary Research
1.7 Information Or Data Analysis
1.7.1 Data Analysis Models
1.8 Market Formulation & Validation
1.9 Model Details
1.9.1 Commodity Flow Analysis
1.10 List Of Secondary Sources
1.11 List Of Abbreviations
1.1.1 Product Segment
1.1.2 Technology Segment
1.1.3 Application Segment
1.2 Regional Scope
1.3 Estimates and Forecast Timeline
1.4 Objectives
1.4.1 Objective - 1
1.4.2 Objective - 2
1.4.3 Objective - 3
1.5 Research Methodology
1.6 Information Procurement
1.6.1 Purchased Database
1.6.2 Gvr’s Internal Database
1.6.3 Secondary Sources
1.6.4 Primary Research
1.7 Information Or Data Analysis
1.7.1 Data Analysis Models
1.8 Market Formulation & Validation
1.9 Model Details
1.9.1 Commodity Flow Analysis
1.10 List Of Secondary Sources
1.11 List Of Abbreviations
Chapter 2 Executive Summary
2.1 Market Summary
2.2 Segment Snapshot
2.3 Competitive Landscape Snapshot
2.2 Segment Snapshot
2.3 Competitive Landscape Snapshot
Chapter 3 Real-Time Pcr (Qpcr) Market - Industry Outlook
3.1 Market Lineage Outlook
3.1.1 Parent Market Lineage Outlook
3.1.2 Related/Ancillary Market Outlook
3.2 Market Dynamics
3.2.1 Market Drivers
3.2.1.1 Rising Incidence Of Chronic Diseases, Infectious Diseases, And Genetic Disorders
3.2.1.2 Technological Advancements In Pcr
3.2.1.3 Implementation Of Miqe Guidelines
3.2.1.4 Increasing Demand For Rapid Diagnostic Tests And Growing Adoption Of Qpcr & Dpcr Technologies
3.2.1.5 Increasing Number Of Cros And Forensic & Research Laboratories
3.2.1.6 Increasing Demand For Prenatal Genetic Testing Procedures
3.2.2 Market Restraint Analysis
3.2.2.1 High Device Costs Associated With Real Time Pcr (Qpcr)
3.2.2.2 Stringent Regulatory Policies
3.3 Comparative Analysis
3.4 Swot Analysis, By Factor (Political & Legal, Economic And Technological)
3.5 Industry Analysis - Porter’s
3.1.1 Parent Market Lineage Outlook
3.1.2 Related/Ancillary Market Outlook
3.2 Market Dynamics
3.2.1 Market Drivers
3.2.1.1 Rising Incidence Of Chronic Diseases, Infectious Diseases, And Genetic Disorders
3.2.1.2 Technological Advancements In Pcr
3.2.1.3 Implementation Of Miqe Guidelines
3.2.1.4 Increasing Demand For Rapid Diagnostic Tests And Growing Adoption Of Qpcr & Dpcr Technologies
3.2.1.5 Increasing Number Of Cros And Forensic & Research Laboratories
3.2.1.6 Increasing Demand For Prenatal Genetic Testing Procedures
3.2.2 Market Restraint Analysis
3.2.2.1 High Device Costs Associated With Real Time Pcr (Qpcr)
3.2.2.2 Stringent Regulatory Policies
3.3 Comparative Analysis
3.4 Swot Analysis, By Factor (Political & Legal, Economic And Technological)
3.5 Industry Analysis - Porter’s
Chapter 4 Real-Time Pcr (Qpcr), End Point Pcr, And Dpcr Market Analysis, Technology Scope, 2018 - 2030 (Revenue, USD Million)
4.1 Real-Time Pcr (Qpcr), End Point Pcr, And Dpcr Market: Technology Movement Analysis
4.2 Quantitative
4.2.1 Quantitative Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.2.2 Consumables & Reagents
4.2.2.1 Consumables & Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.2.3 Instruments
4.2.3.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.2.4 Software & Services
4.2.4.1 Software & Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.3 Digital
4.3.1 Digital Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.3.2 Consumables & Reagents
4.3.2.1 Consumables & Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.3.3 Instruments
4.3.3.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.3.4 Software & Services
4.3.4.1 Software & Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.4 End-Point Pcr
4.4.1 End-Point Pcr Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.4.2 Consumables & Reagents
4.4.2.1 Consumables & Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.4.3 Instruments
4.4.3.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.4.4 Software & Services
4.4.4.1 Software & Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.2 Quantitative
4.2.1 Quantitative Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.2.2 Consumables & Reagents
4.2.2.1 Consumables & Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.2.3 Instruments
4.2.3.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.2.4 Software & Services
4.2.4.1 Software & Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.3 Digital
4.3.1 Digital Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.3.2 Consumables & Reagents
4.3.2.1 Consumables & Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.3.3 Instruments
4.3.3.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.3.4 Software & Services
4.3.4.1 Software & Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.4 End-Point Pcr
4.4.1 End-Point Pcr Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.4.2 Consumables & Reagents
4.4.2.1 Consumables & Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.4.3 Instruments
4.4.3.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
4.4.4 Software & Services
4.4.4.1 Software & Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 5 Real-Time Pcr (Qpcr), End Point Pcr, And Dpcr Market Analysis, Product Scope, 2018 - 2030 (Revenue, USD Million)
5.1 Real-Time Pcr (Qpcr), End Point Pcr, And Dpcr Market: Products Movement Analysis
5.2 Consumables & Reagents
5.2.1 Consumables & Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.3 Instruments
5.3.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.4 Software & Services
5.4.1 Software & Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.2 Consumables & Reagents
5.2.1 Consumables & Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.3 Instruments
5.3.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.4 Software & Services
5.4.1 Software & Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 6 Real-Time Pcr (Qpcr), End Point Pcr, And Dpcr Market Analysis, Application Scope, 2018 - 2030 (Revenue, USD Million)
6.1 Real-Time Pcr (Qpcr), End Point Pcr, And Dpcr Market: Application Movement Analysis
6.2 Clinical
6.2.1 Clinical Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.2.2 Pathogen Testing
6.2.2.1 Pathogen Testing Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.2.3 Oncology Testing
6.2.3.1 Oncology Testing Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.2.4 Blood Screening
6.2.4.1 Blood Screening Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.2.5 Liquid Biopsy Testing
6.2.5.1 Liquid Biopsy Testing Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.2.6 Dpcr-Based Non-Invasive Prenatal Testing (Nipt)
6.2.6.1 Dpcr-Based Non-Invasive Prenatal Testing (Nipt) Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.2.7 Others
6.2.7.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3 Research
6.3.1 Research Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3.2 Stem Cell Research
6.3.2.1 Stem Cell Research Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3.3 Dna Cloning & Sequencing
6.3.3.1 Dna Cloning & Sequencing Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3.4 Recombinant Dna Technology
6.3.4.1 Recombinant Dna Technology Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3.5 Rare Mutation Detection
6.3.5.1 Rare Mutation Detection Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3.6 Gene Expression
6.3.6.1 Gene Expression Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3.7 Single-Cell Analysis
6.3.7.1 Single-Cell Analysis Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3.8 Microbiome Analysis
6.3.8.1 Microbiome Analysis Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3.9 Copy Number Variation Analysis
6.3.9.1 Copy Number Variation Analysis Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3.10 Library Quantification (Ngs)
6.3.10.1 Library Quantification (Ngs) Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3.11 Characterization Of Low-Fold Changes In Mrna And Mirna Expression
6.3.11.1 Characterization Of Low-Fold Changes In Mrna And Mirna Expression Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3.12 Species Identification
6.3.12.1 Species Identification Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3.13 Gmo Detection
6.3.13.1 GMO detection market estimates and forecast, 2018 - 2030 (USD Million)
6.4 Forensics and Others
6.4.1.1 Forensics and others market estimates and forecast, 2018 - 2030 (USD Million)
6.2 Clinical
6.2.1 Clinical Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.2.2 Pathogen Testing
6.2.2.1 Pathogen Testing Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.2.3 Oncology Testing
6.2.3.1 Oncology Testing Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.2.4 Blood Screening
6.2.4.1 Blood Screening Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.2.5 Liquid Biopsy Testing
6.2.5.1 Liquid Biopsy Testing Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.2.6 Dpcr-Based Non-Invasive Prenatal Testing (Nipt)
6.2.6.1 Dpcr-Based Non-Invasive Prenatal Testing (Nipt) Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.2.7 Others
6.2.7.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3 Research
6.3.1 Research Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3.2 Stem Cell Research
6.3.2.1 Stem Cell Research Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3.3 Dna Cloning & Sequencing
6.3.3.1 Dna Cloning & Sequencing Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3.4 Recombinant Dna Technology
6.3.4.1 Recombinant Dna Technology Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3.5 Rare Mutation Detection
6.3.5.1 Rare Mutation Detection Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3.6 Gene Expression
6.3.6.1 Gene Expression Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3.7 Single-Cell Analysis
6.3.7.1 Single-Cell Analysis Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3.8 Microbiome Analysis
6.3.8.1 Microbiome Analysis Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3.9 Copy Number Variation Analysis
6.3.9.1 Copy Number Variation Analysis Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3.10 Library Quantification (Ngs)
6.3.10.1 Library Quantification (Ngs) Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3.11 Characterization Of Low-Fold Changes In Mrna And Mirna Expression
6.3.11.1 Characterization Of Low-Fold Changes In Mrna And Mirna Expression Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3.12 Species Identification
6.3.12.1 Species Identification Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.3.13 Gmo Detection
6.3.13.1 GMO detection market estimates and forecast, 2018 - 2030 (USD Million)
6.4 Forensics and Others
6.4.1.1 Forensics and others market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 7 Real-time PCR (qPCR), end point PCR, and dPCR Market Analysis, Regional Scope, 2018 - 2030 (Revenue, USD Million)
7.1 Market Share Analysis by Country, 2022 & 2030
7.1.1 North America
7.1.1.1 North America market estimates and forecast, 2018 - 2030 (USD Million)
7.1.1.2 U.S.
7.1.1.2.1 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
7.1.1.2.2 Key country dynamics
7.1.1.2.3 Competitive scenario
7.1.1.2.4 Regulatory framework
7.1.1.3 Canada
7.1.1.3.1 Canada market estimates and forecast, 2018 - 2030 (USD Million)
7.1.1.3.2 Key country dynamics
7.1.1.3.3 Competitive scenario
7.1.1.3.4 Regulatory framework
7.1.2 EUROPE
7.1.2.1 Europe market estimates and forecast, 2018 - 2030 (USD Million)
7.1.2.2 UK
7.1.2.2.1 UK market estimates and forecast, 2018 - 2030 (USD Million)
7.1.2.2.2 Key country dynamics
7.1.2.2.3 Competitive scenario
7.1.2.2.4 Regulatory framework
7.1.2.3 Germany
7.1.2.3.1 Germany market estimates and forecast, 2018 - 2030 (USD Million)
7.1.2.3.2 Key country dynamics
7.1.2.3.3 Competitive scenario
7.1.2.3.4 Regulatory framework
7.1.2.4 France
7.1.2.4.1 France market estimates and forecast, 2018 - 2030 (USD Million)
7.1.2.4.2 Key country dynamics
7.1.2.4.3 Competitive scenario
7.1.2.4.4 Regulatory framework
7.1.2.5 Italy
7.1.2.5.1 Italy market estimates and forecast, 2018 - 2030 (USD Million)
7.1.2.5.2 Key country dynamics
7.1.2.5.3 Competitive scenario
7.1.2.5.4 Regulatory framework
7.1.2.6 Spain
7.1.2.6.1 Spain market estimates and forecast, 2018 - 2030 (USD Million)
7.1.2.6.2 Key country dynamics
7.1.2.6.3 Competitive scenario
7.1.2.6.4 Regulatory framework
7.1.2.7 Denmark
7.1.2.7.1 Denmark market estimates and forecast, 2018 - 2030 (USD Million)
7.1.2.7.2 Key country dynamics
7.1.2.7.3 Competitive scenario
7.1.2.7.4 Regulatory framework
7.1.2.8 Sweden
7.1.2.8.1 Sweden market estimates and forecast, 2018 - 2030 (USD Million)
7.1.2.8.2 Key country dynamics
7.1.2.8.3 Competitive scenario
7.1.2.8.4 Regulatory framework
7.1.2.9 Norway
7.1.2.9.1 Norway market estimates and forecast, 2018 - 2030 (USD Million)
7.1.2.9.2 Key country dynamics
7.1.2.9.3 Competitive scenario
7.1.2.9.4 Regulatory framework
7.1.3 Asia-Pacific
7.1.3.1 Asia-Pacific market estimates and forecast, 2018 - 2030 (USD Million)
7.1.3.2 Japan
7.1.3.2.1 Japan market estimates and forecast, 2018 - 2030 (USD Million)
7.1.3.2.2 Key country dynamics
7.1.3.2.3 Competitive scenario
7.1.3.2.4 Regulatory framework
7.1.3.3 India
7.1.3.3.1 India market estimates and forecast, 2018 - 2030 (USD Million)
7.1.3.3.2 Key country dynamics
7.1.3.3.3 Competitive scenario
7.1.3.3.4 Regulatory framework
7.1.3.4 Australia
7.1.3.4.1 Australia market estimates and forecast, 2018 - 2030 (USD Million)
7.1.3.4.2 Key country dynamics
7.1.3.4.3 Competitive scenario
7.1.3.4.4 Regulatory framework
7.1.3.5 China
7.1.3.5.1 China market estimates and forecast, 2018 - 2030 (USD Million)
7.1.3.5.2 Key country dynamics
7.1.3.5.3 Competitive scenario
7.1.3.5.4 Regulatory framework
7.1.3.6 South Korea
7.1.3.6.1 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
7.1.3.6.2 Key country dynamics
7.1.3.6.3 Competitive scenario
7.1.3.6.4 Regulatory framework
7.1.3.7 Thailand
7.1.3.7.1 Thailand market estimates and forecast, 2018 - 2030 (USD Million)
7.1.3.7.2 Key country dynamics
7.1.3.7.3 Competitive scenario
7.1.3.7.4 Regulatory framework
7.1.4 Latin America
7.1.4.1 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
7.1.4.2 Brazil
7.1.4.2.1 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
7.1.4.2.2 Key country dynamics
7.1.4.2.3 Competitive scenario
7.1.4.2.4 Regulatory framework
7.1.4.3 Mexico
7.1.4.3.1 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
7.1.4.3.2 Key country dynamics
7.1.4.3.3 Competitive scenario
7.1.4.3.4 Regulatory framework
7.1.4.4 Argentina
7.1.4.4.1 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
7.1.4.4.2 Key country dynamics
7.1.4.4.3 Competitive scenario
7.1.4.4.4 Regulatory framework
7.1.5 Middle East & Africa
7.1.5.1 Middle East & Africa market estimates and forecast, 2018 - 2030 (USD Million)
7.1.5.2 South Africa
7.1.5.2.1 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
7.1.5.2.2 Key country dynamics
7.1.5.2.3 Competitive scenario
7.1.5.2.4 Regulatory framework
7.1.5.3 Saudi Arabia
7.1.5.3.1 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
7.1.5.3.2 Key country dynamics
7.1.5.3.3 Competitive scenario
7.1.5.3.4 Regulatory framework
7.1.5.4 UAE
7.1.5.4.1 UAE market estimates and forecast, 2018 - 2030 (USD Million)
7.1.5.4.2 Key country dynamics
7.1.5.4.3 Competitive scenario
7.1.5.4.4 Regulatory framework
7.1.5.5 Kuwait
7.1.5.5.1 Kuwait market estimates and forecast, 2018 - 2030 (USD Million)
7.1.5.5.2 Key country dynamics
7.1.5.5.3 Competitive scenario
7.1.5.5.4 Regulatory framework
7.1.1 North America
7.1.1.1 North America market estimates and forecast, 2018 - 2030 (USD Million)
7.1.1.2 U.S.
7.1.1.2.1 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
7.1.1.2.2 Key country dynamics
7.1.1.2.3 Competitive scenario
7.1.1.2.4 Regulatory framework
7.1.1.3 Canada
7.1.1.3.1 Canada market estimates and forecast, 2018 - 2030 (USD Million)
7.1.1.3.2 Key country dynamics
7.1.1.3.3 Competitive scenario
7.1.1.3.4 Regulatory framework
7.1.2 EUROPE
7.1.2.1 Europe market estimates and forecast, 2018 - 2030 (USD Million)
7.1.2.2 UK
7.1.2.2.1 UK market estimates and forecast, 2018 - 2030 (USD Million)
7.1.2.2.2 Key country dynamics
7.1.2.2.3 Competitive scenario
7.1.2.2.4 Regulatory framework
7.1.2.3 Germany
7.1.2.3.1 Germany market estimates and forecast, 2018 - 2030 (USD Million)
7.1.2.3.2 Key country dynamics
7.1.2.3.3 Competitive scenario
7.1.2.3.4 Regulatory framework
7.1.2.4 France
7.1.2.4.1 France market estimates and forecast, 2018 - 2030 (USD Million)
7.1.2.4.2 Key country dynamics
7.1.2.4.3 Competitive scenario
7.1.2.4.4 Regulatory framework
7.1.2.5 Italy
7.1.2.5.1 Italy market estimates and forecast, 2018 - 2030 (USD Million)
7.1.2.5.2 Key country dynamics
7.1.2.5.3 Competitive scenario
7.1.2.5.4 Regulatory framework
7.1.2.6 Spain
7.1.2.6.1 Spain market estimates and forecast, 2018 - 2030 (USD Million)
7.1.2.6.2 Key country dynamics
7.1.2.6.3 Competitive scenario
7.1.2.6.4 Regulatory framework
7.1.2.7 Denmark
7.1.2.7.1 Denmark market estimates and forecast, 2018 - 2030 (USD Million)
7.1.2.7.2 Key country dynamics
7.1.2.7.3 Competitive scenario
7.1.2.7.4 Regulatory framework
7.1.2.8 Sweden
7.1.2.8.1 Sweden market estimates and forecast, 2018 - 2030 (USD Million)
7.1.2.8.2 Key country dynamics
7.1.2.8.3 Competitive scenario
7.1.2.8.4 Regulatory framework
7.1.2.9 Norway
7.1.2.9.1 Norway market estimates and forecast, 2018 - 2030 (USD Million)
7.1.2.9.2 Key country dynamics
7.1.2.9.3 Competitive scenario
7.1.2.9.4 Regulatory framework
7.1.3 Asia-Pacific
7.1.3.1 Asia-Pacific market estimates and forecast, 2018 - 2030 (USD Million)
7.1.3.2 Japan
7.1.3.2.1 Japan market estimates and forecast, 2018 - 2030 (USD Million)
7.1.3.2.2 Key country dynamics
7.1.3.2.3 Competitive scenario
7.1.3.2.4 Regulatory framework
7.1.3.3 India
7.1.3.3.1 India market estimates and forecast, 2018 - 2030 (USD Million)
7.1.3.3.2 Key country dynamics
7.1.3.3.3 Competitive scenario
7.1.3.3.4 Regulatory framework
7.1.3.4 Australia
7.1.3.4.1 Australia market estimates and forecast, 2018 - 2030 (USD Million)
7.1.3.4.2 Key country dynamics
7.1.3.4.3 Competitive scenario
7.1.3.4.4 Regulatory framework
7.1.3.5 China
7.1.3.5.1 China market estimates and forecast, 2018 - 2030 (USD Million)
7.1.3.5.2 Key country dynamics
7.1.3.5.3 Competitive scenario
7.1.3.5.4 Regulatory framework
7.1.3.6 South Korea
7.1.3.6.1 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
7.1.3.6.2 Key country dynamics
7.1.3.6.3 Competitive scenario
7.1.3.6.4 Regulatory framework
7.1.3.7 Thailand
7.1.3.7.1 Thailand market estimates and forecast, 2018 - 2030 (USD Million)
7.1.3.7.2 Key country dynamics
7.1.3.7.3 Competitive scenario
7.1.3.7.4 Regulatory framework
7.1.4 Latin America
7.1.4.1 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
7.1.4.2 Brazil
7.1.4.2.1 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
7.1.4.2.2 Key country dynamics
7.1.4.2.3 Competitive scenario
7.1.4.2.4 Regulatory framework
7.1.4.3 Mexico
7.1.4.3.1 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
7.1.4.3.2 Key country dynamics
7.1.4.3.3 Competitive scenario
7.1.4.3.4 Regulatory framework
7.1.4.4 Argentina
7.1.4.4.1 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
7.1.4.4.2 Key country dynamics
7.1.4.4.3 Competitive scenario
7.1.4.4.4 Regulatory framework
7.1.5 Middle East & Africa
7.1.5.1 Middle East & Africa market estimates and forecast, 2018 - 2030 (USD Million)
7.1.5.2 South Africa
7.1.5.2.1 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
7.1.5.2.2 Key country dynamics
7.1.5.2.3 Competitive scenario
7.1.5.2.4 Regulatory framework
7.1.5.3 Saudi Arabia
7.1.5.3.1 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
7.1.5.3.2 Key country dynamics
7.1.5.3.3 Competitive scenario
7.1.5.3.4 Regulatory framework
7.1.5.4 UAE
7.1.5.4.1 UAE market estimates and forecast, 2018 - 2030 (USD Million)
7.1.5.4.2 Key country dynamics
7.1.5.4.3 Competitive scenario
7.1.5.4.4 Regulatory framework
7.1.5.5 Kuwait
7.1.5.5.1 Kuwait market estimates and forecast, 2018 - 2030 (USD Million)
7.1.5.5.2 Key country dynamics
7.1.5.5.3 Competitive scenario
7.1.5.5.4 Regulatory framework
Chapter 8 Real-time PCR (qPCR), end point PCR, and dPCR Market - Competitive Landscape
8.1 Company Categorization
8.2 Strategy Mapping
8.2.1 New Product Launch
8.2.2 Partnership
8.2.3 Acquisition
8.2.4 Collaboration
8.2.5 Funding
8.3 Key Company Market Share Analysis, 2022
8.4 Company Profiles
8.4.1 Abbott
8.4.1.1 Company overview
8.4.1.2 Financial performance
8.4.1.3 Product benchmarking
8.4.1.4 Strategic initiatives
8.4.2 Qiagen
8.4.2.1 Company overview
8.4.2.2 Financial performance
8.4.2.3 Product benchmarking
8.4.2.4 Strategic initiatives
8.4.3 Bio-Rad Laboratories Inc.
8.4.3.1 Company overview
8.4.3.2 Financial performance
8.4.3.3 Product benchmarking
8.4.3.4 Strategic initiatives
8.4.4 Agilent Technologies, Inc.
8.4.4.1 Company overview
8.4.4.2 Financial performance
8.4.4.3 Product benchmarking
8.4.4.4 Strategic initiatives
8.4.5 Thermo Fisher Scientific, Inc.
8.4.5.1 Company overview
8.4.5.2 Affymetrix
8.4.5.3 Company overview
8.4.5.4 Financial performance
8.4.5.5 Product benchmarking
8.4.5.6 Strategic initiatives
8.4.6 Cytiva (GE HEALTHCARE)
8.4.6.1 Company overview
8.4.6.2 Financial performance
8.4.6.3 Product benchmarking
8.4.6.4 Strategic initiatives
8.4.7 BIOMÉRIEUX SA
8.4.7.1 Company overview
8.4.7.2 Financial performance
8.4.7.3 Product benchmarking
8.4.7.4 Strategic initiatives
8.4.8 F. Hoffmann-La Roche Ltd
8.4.8.1 Company overview
8.4.8.2 Financial performance
8.4.8.3 Product benchmarking
8.4.8.4 Strategic initiatives
8.4.9 Fluidigm Corporation
8.4.9.1 Company overview
8.4.9.2 Financial performance
8.4.9.3 Product benchmarking
8.4.9.4 Strategic initiatives
8.4.10 Stilla
8.4.10.1 COMPANY OVERVIEW
8.4.10.2 Product benchmarking
8.4.10.3 Strategic initiatives
8.4.11 Microsynth Ag
8.4.11.1 Company overview
8.4.11.2 Product benchmarking
8.4.11.3 Strategic initiatives
8.4.12 Jn Medsys
8.4.12.1 Company overview
8.4.12.2 Product benchmarking
8.4.12.3 Strategic initiatives
8.4.13 Danaher
8.4.13.1 Company overview
8.4.13.2 Cepheid
8.4.13.3 Financial performance
8.4.13.4 Product benchmarking
8.4.13.5 Strategic initiatives
8.2 Strategy Mapping
8.2.1 New Product Launch
8.2.2 Partnership
8.2.3 Acquisition
8.2.4 Collaboration
8.2.5 Funding
8.3 Key Company Market Share Analysis, 2022
8.4 Company Profiles
8.4.1 Abbott
8.4.1.1 Company overview
8.4.1.2 Financial performance
8.4.1.3 Product benchmarking
8.4.1.4 Strategic initiatives
8.4.2 Qiagen
8.4.2.1 Company overview
8.4.2.2 Financial performance
8.4.2.3 Product benchmarking
8.4.2.4 Strategic initiatives
8.4.3 Bio-Rad Laboratories Inc.
8.4.3.1 Company overview
8.4.3.2 Financial performance
8.4.3.3 Product benchmarking
8.4.3.4 Strategic initiatives
8.4.4 Agilent Technologies, Inc.
8.4.4.1 Company overview
8.4.4.2 Financial performance
8.4.4.3 Product benchmarking
8.4.4.4 Strategic initiatives
8.4.5 Thermo Fisher Scientific, Inc.
8.4.5.1 Company overview
8.4.5.2 Affymetrix
8.4.5.3 Company overview
8.4.5.4 Financial performance
8.4.5.5 Product benchmarking
8.4.5.6 Strategic initiatives
8.4.6 Cytiva (GE HEALTHCARE)
8.4.6.1 Company overview
8.4.6.2 Financial performance
8.4.6.3 Product benchmarking
8.4.6.4 Strategic initiatives
8.4.7 BIOMÉRIEUX SA
8.4.7.1 Company overview
8.4.7.2 Financial performance
8.4.7.3 Product benchmarking
8.4.7.4 Strategic initiatives
8.4.8 F. Hoffmann-La Roche Ltd
8.4.8.1 Company overview
8.4.8.2 Financial performance
8.4.8.3 Product benchmarking
8.4.8.4 Strategic initiatives
8.4.9 Fluidigm Corporation
8.4.9.1 Company overview
8.4.9.2 Financial performance
8.4.9.3 Product benchmarking
8.4.9.4 Strategic initiatives
8.4.10 Stilla
8.4.10.1 COMPANY OVERVIEW
8.4.10.2 Product benchmarking
8.4.10.3 Strategic initiatives
8.4.11 Microsynth Ag
8.4.11.1 Company overview
8.4.11.2 Product benchmarking
8.4.11.3 Strategic initiatives
8.4.12 Jn Medsys
8.4.12.1 Company overview
8.4.12.2 Product benchmarking
8.4.12.3 Strategic initiatives
8.4.13 Danaher
8.4.13.1 Company overview
8.4.13.2 Cepheid
8.4.13.3 Financial performance
8.4.13.4 Product benchmarking
8.4.13.5 Strategic initiatives
List of Tables
Table 1: List of key distributors and channel partners
Table 2: List of key emerging companies’ /technology disruptors/innovators
Table 3: North America real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 4: North America real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 5: North America qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 6: North America qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 7: North America qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 8: North America real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 9: North America real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 10: U.S. real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 11: U.S. real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 12: U.S. qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 13: U.S. qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 14: U.S. qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 15: U.S. real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 16: U.S. real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 17: Canada real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 18: Canada real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 19: Canada qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 20: Canada qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 21: Canada qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 22: Canada real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 23: Canada real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 24: Europe real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 25: Europe real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 26: Europe qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 27: Europe qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 28: Europe qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 29: Europe real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 30: Europe real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 31: U.K. real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 32: U.K. real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 33: U.K. qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 34: U.K. qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 35: U.K. qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 36: U.K. real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 37: U.K. real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 38: Germany real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 39: Germany real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 40: Germany qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 41: Germany qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 42: Germany qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 43: Germany real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 44: Germany real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 45: Italy real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 46: Italy real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 47: Italy qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 48: Italy qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 49: Italy qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 50: Italy real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 51: Italy real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 52: Spain real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 53: Spain real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 54: Spain qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 55: Spain qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 56: Spain qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 57: Spain real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 58: Spain real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 59: France real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 60: France real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 61: France qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 62: France qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 63: France qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 64: France real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 65: France real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 66: Denmark real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 67: Denmark real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 68: Denmark qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 69: Denmark qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 70: Denmark qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 71: Denmark real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 72: Denmark real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 73: Sweden real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 74: Sweden real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 75: Sweden qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 76: Sweden qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 77: Sweden qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 78: Sweden real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 79: Sweden real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 80: Norway real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 81: Norway real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 82: Norway qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 83: Norway qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 84: Norway qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 85: Norway real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 86: Norway real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 87: Asia Pacific real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 88: Asia Pacific real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 89: Asia Pacific qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 90: Asia Pacific qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 91: Asia Pacific qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 92: Asia Pacific real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 93: Asia Pacific real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 94: China real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 95: China real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 96: China qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 97: China qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 98: China qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 99: China real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 100: China real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 101: Japan real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 102: Japan real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 103: Japan qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 104: Japan qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 105: Japan qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 106: Japan real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 107: Japan real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 108: India real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 109: India real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 110: India qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 111: India qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 112: India qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 113: India real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 114: India real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 115: Australia real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 116: Australia real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 117: Australia qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 118: Australia qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 119: Australia qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 120: Australia real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 121: Australia real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 122: South Korea real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 123: South Korea real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 124: South Korea qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 125: South Korea qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 126: South Korea qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 127: South Korea real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 128: South Korea real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 129: Thailand real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 130: Thailand real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 131: Thailand qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 132: Thailand qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 133: Thailand qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 134: Thailand real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 135: Thailand real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 136: Latin America real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 137: Latin America real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 138: Latin America qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 139: Latin America qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 140: Latin America qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 141: Latin America real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 142: Latin America real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 143: Brazil real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 144: Brazil real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 145: Brazil qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 146: Brazil qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 147: Brazil qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 148: Brazil real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 149: Brazil real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 150: Mexico real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 151: Mexico real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 152: Mexico qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 153: Mexico qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 154: Mexico qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 155: Mexico real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 156: Mexico real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 157: Argentina real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 158: Argentina real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 159: Argentina qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 160: Argentina qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 161: Argentina qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 162: Argentina real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 163: Argentina real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 164: MEA real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 165: MEA real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 166: MEA qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 167: MEA qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 168: MEA qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 169: MEA real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 170: MEA real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 171: South Africa real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 172: South Africa real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 173: South Africa qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 174: South Africa qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 175: South Africa qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 176: South Africa real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 178: South Africa real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 178: Saudi Arabia real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 179: Saudi Arabia real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 180: Saudi Arabia qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 181: Saudi Arabia qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 182: Saudi Arabia qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 183: Saudi Arabia real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 184: Saudi Arabia real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 185: UAE real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 186: UAE real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 187: UAE qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 188: UAE qPCR and dPCR instruments market , by technology, 2018-2030 (USD Million)
Table 189: UAE qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 190: UAE real time PCR, digital PCR and end-point PCR market , by application, 2018-2030 (USD Million)
Table 191: UAE real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 192: Kuwait real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 193: Kuwait real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 194: Kuwait qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 195: Kuwait qPCR and dPCR instruments market , by technology, 2018-2030 (USD Million)
Table 196: Kuwait qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 197: Kuwait real time PCR, digital PCR and end-point PCR market , by application, 2018-2030 (USD Million)
Table 198: Kuwait real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 2: List of key emerging companies’ /technology disruptors/innovators
Table 3: North America real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 4: North America real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 5: North America qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 6: North America qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 7: North America qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 8: North America real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 9: North America real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 10: U.S. real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 11: U.S. real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 12: U.S. qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 13: U.S. qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 14: U.S. qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 15: U.S. real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 16: U.S. real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 17: Canada real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 18: Canada real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 19: Canada qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 20: Canada qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 21: Canada qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 22: Canada real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 23: Canada real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 24: Europe real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 25: Europe real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 26: Europe qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 27: Europe qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 28: Europe qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 29: Europe real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 30: Europe real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 31: U.K. real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 32: U.K. real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 33: U.K. qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 34: U.K. qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 35: U.K. qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 36: U.K. real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 37: U.K. real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 38: Germany real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 39: Germany real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 40: Germany qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 41: Germany qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 42: Germany qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 43: Germany real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 44: Germany real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 45: Italy real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 46: Italy real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 47: Italy qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 48: Italy qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 49: Italy qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 50: Italy real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 51: Italy real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 52: Spain real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 53: Spain real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 54: Spain qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 55: Spain qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 56: Spain qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 57: Spain real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 58: Spain real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 59: France real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 60: France real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 61: France qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 62: France qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 63: France qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 64: France real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 65: France real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 66: Denmark real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 67: Denmark real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 68: Denmark qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 69: Denmark qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 70: Denmark qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 71: Denmark real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 72: Denmark real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 73: Sweden real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 74: Sweden real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 75: Sweden qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 76: Sweden qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 77: Sweden qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 78: Sweden real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 79: Sweden real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 80: Norway real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 81: Norway real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 82: Norway qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 83: Norway qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 84: Norway qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 85: Norway real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 86: Norway real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 87: Asia Pacific real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 88: Asia Pacific real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 89: Asia Pacific qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 90: Asia Pacific qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 91: Asia Pacific qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 92: Asia Pacific real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 93: Asia Pacific real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 94: China real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 95: China real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 96: China qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 97: China qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 98: China qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 99: China real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 100: China real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 101: Japan real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 102: Japan real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 103: Japan qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 104: Japan qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 105: Japan qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 106: Japan real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 107: Japan real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 108: India real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 109: India real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 110: India qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 111: India qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 112: India qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 113: India real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 114: India real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 115: Australia real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 116: Australia real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 117: Australia qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 118: Australia qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 119: Australia qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 120: Australia real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 121: Australia real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 122: South Korea real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 123: South Korea real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 124: South Korea qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 125: South Korea qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 126: South Korea qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 127: South Korea real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 128: South Korea real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 129: Thailand real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 130: Thailand real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 131: Thailand qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 132: Thailand qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 133: Thailand qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 134: Thailand real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 135: Thailand real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 136: Latin America real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 137: Latin America real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 138: Latin America qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 139: Latin America qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 140: Latin America qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 141: Latin America real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 142: Latin America real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 143: Brazil real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 144: Brazil real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 145: Brazil qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 146: Brazil qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 147: Brazil qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 148: Brazil real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 149: Brazil real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 150: Mexico real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 151: Mexico real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 152: Mexico qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 153: Mexico qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 154: Mexico qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 155: Mexico real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 156: Mexico real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 157: Argentina real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 158: Argentina real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 159: Argentina qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 160: Argentina qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 161: Argentina qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 162: Argentina real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 163: Argentina real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 164: MEA real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 165: MEA real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 166: MEA qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 167: MEA qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 168: MEA qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 169: MEA real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 170: MEA real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 171: South Africa real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 172: South Africa real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 173: South Africa qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 174: South Africa qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 175: South Africa qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 176: South Africa real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 178: South Africa real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 178: Saudi Arabia real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 179: Saudi Arabia real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 180: Saudi Arabia qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 181: Saudi Arabia qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 182: Saudi Arabia qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 183: Saudi Arabia real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 184: Saudi Arabia real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 185: UAE real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 186: UAE real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 187: UAE qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 188: UAE qPCR and dPCR instruments market , by technology, 2018-2030 (USD Million)
Table 189: UAE qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 190: UAE real time PCR, digital PCR and end-point PCR market , by application, 2018-2030 (USD Million)
Table 191: UAE real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 192: Kuwait real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 193: Kuwait real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 194: Kuwait qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 195: Kuwait qPCR and dPCR instruments market , by technology, 2018-2030 (USD Million)
Table 196: Kuwait qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 197: Kuwait real time PCR, digital PCR and end-point PCR market , by application, 2018-2030 (USD Million)
Table 198: Kuwait real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
List of Figures
Fig. 1: Real-time PCR (qPCR), end point PCR, and dPCR market segmentation
Fig. 2: Market research process
Fig. 3: Data triangulation techniques
Fig. 4: Primary research pattern
Fig. 5: Market research approaches
Fig. 6: Value-chain-based sizing & forecasting
Fig. 7: QFD modeling for market share assessment
Fig. 8: Market formulation & validation
Fig. 9: Real-time PCR (qPCR), end point PCR, and dPCR market snapshot
Fig. 10: Parent market outlook
Fig. 11: Related/ancillary market outlook
Fig. 12: Penetration and growth prospect mapping
Fig. 13: Real-time PCR (qPCR), end point PCR, and dPCR market driver impact
Fig. 14: Real-time PCR (qPCR), end point PCR, and dPCR market restraint impact
Fig. 15: SWOT analysis, by factor (Political & legal, economic, and technological)
Fig. 16: Industry Analysis - Porter’s
Fig. 17: Strategy mapping
Fig. 18: Ansoff Matrix
Fig. 19: Competitive dashboard analysis
Fig. 20: Regional network map
Fig. 21: Real-time PCR (qPCR), end point PCR, and dPCR market: Technology outlook and key takeaways
Fig. 22: Real-time PCR (qPCR), end point PCR, and dPCR market: Technology movement analysis& market share 2022 & 2030
Fig. 23: Quantitative market estimates and forecast, 2018-2030(USD Million)
Fig. 24: Digital market estimates and forecast, 2018-2030 (USD Million)
Fig. 25: End-point PCR market estimates and forecast, 2018-2030(USD Million)
Fig. 26: Real-time PCR (qPCR), end point PCR, and dPCR market: Products outlook and key takeaways
Fig. 27: Real-time PCR (qPCR), end point PCR, and dPCR market: Products movement analysis & market share 2022 & 2030
Fig. 28: Consumables & reagents market estimates and forecast, 2018-2030 (USD Million)
Fig. 29: Instruments market estimates and forecast, 2018-2030 (USD Million)
Fig. 30: Software & services market estimates and forecast, 2018-2030 (USD Million)
Fig. 31: Real-time PCR (qPCR), end point PCR, and dPCR market: Application outlook and key takeaways
Fig. 32: Real-time PCR (qPCR), end point PCR, and dPCR market: Application movement analysis & market share 2022 & 2030
Fig. 33: Clinical market estimates and forecast, 2018-2030 (USD Million)
Fig. 34: Pathogen testing market estimates and forecast, 2018-2030 (USD Million)
Fig. 35: Oncology testing market estimates and forecast, 2018-2030 (USD Million)
Fig. 36: Blood screening market estimates and forecast, 2018-2030 (USD Million)
Fig. 37: Liquid Biopsy testing market estimates and forecast, 2018-2030 (USD Million)
Fig. 38: dPCR-based Non-Invasive Prenatal Testing (NIPT) market estimates and forecast, 2018-2030 (USD Million)
Fig. 39: Others market estimates and forecast, 2018-2030 (USD Million)
Fig. 40: Research market estimates and forecast, 2018-2030 (USD Million)
Fig. 41: Stem cell research market estimates and forecast, 2018-2030 (USD Million)
Fig. 42: DNA cloning & sequencing market estimates and forecast, 2018-2030 (USD Million)
Fig. 43: Recombinant DNA technology market estimates and forecast, 2018-2030 (USD Million)
Fig. 44: Rare mutation detection market estimates and forecast, 2018-2030 (USD Million)
Fig. 45: Gene expression market estimates and forecast, 2018-2030 (USD Million)
Fig. 46: Single-cell analysis market estimates and forecast, 2018-2030 (USD Million)
Fig. 47: Microbiome analysis market estimates and forecast, 2018-2030 (USD Million)
Fig. 48: Copy number variation analysis market estimates and forecast, 2018-2030 (USD Million)
Fig. 49: Library quantification (NGS) market estimates and forecast, 2018-2030 (USD Million)
Fig. 50: Characterization of low-fold changes in mRNA and miRNA expression market estimates and forecast, 2018-2030 (USD Million)
Fig. 51: Species identification market estimates and forecast, 2018-2030 (USD Million)
Fig. 52: GMO detection market estimates and forecast, 2018-2030 (USD Million)
Fig. 53: Forensics and others market estimates and forecast, 2018-2030 (USD Million)
Fig. 54: Real-time PCR (qPCR), end point PCR, and dPCR market: Regional outlook and key takeaways
Fig. 55: Regional outlook, 2022 & 2030
Fig. 56: North America
Fig. 57: North America. market estimates and forecast, 2018-2030 (USD Million)
Fig. 58: U.S.
Fig. 59: U.S. market estimates and forecast, 2018-2030 (USD Million)
Fig. 60: Canada
Fig. 61: Canada market estimates and forecast, 2018-2030 (USD Million)
Fig. 62: Europe
Fig. 63: Europe market estimates and forecast, 2018-2030 (USD Million)
Fig. 64: UK
Fig. 65: UK market estimates and forecast, 2018-2030 (USD Million)
Fig. 66: Germany
Fig. 67: Germany market estimates and forecast, 2018-2030 (USD Million)
Fig. 68: France
Fig. 69: France market estimates and forecast, 2018-2030 (USD Million)
Fig. 70: Italy
Fig. 71: Italy market estimates and forecast, 2018-2030 (USD Million)
Fig. 72: Spain
Fig. 73: Spain market estimates and forecast, 2018-2030 (USD Million)
Fig. 74: Denmark
Fig. 75: Denmark market estimates and forecast, 2018-2030 (USD Million)
Fig. 76: Sweden
Fig. 77: Sweden market estimates and forecast, 2018-2030 (USD Million)
Fig. 78: Norway
Fig. 79: Norway market estimates and forecast, 2018-2030 (USD Million)
Fig. 80: Asia-Pacific
Fig. 81: Asia-Pacific market estimates and forecast, 2018-2030 (USD Million)
Fig. 82: Japan
Fig. 83: Japan market estimates and forecast, 2018-2030(USD Million)
Fig. 84: India
Fig. 85: India. market estimates and forecast, 2018-2030 (USD Million)
Fig. 86: China
Fig. 87: China market estimates and forecast, 2018-2030 (USD Million)
Fig. 88: Australia
Fig. 89: Australia market estimates and forecast, 2018-2030 (USD Million)
Fig. 90: South Korea
Fig. 91: South Korea market estimates and forecast, 2018-2030 (USD Million)
Fig. 92: Thailand
Fig. 93: Thailand market estimates and forecast, 2018-2030 (USD Million)
Fig. 94: Latin America
Fig. 95: Latin America. market estimates and forecast, 2018-2030 (USD Million)
Fig. 96: Brazil
Fig. 97: Brazil market estimates and forecast, 2018-2030 (USD Million)
Fig. 98: Mexico
Fig. 99: Mexico market estimates and forecast, 2018-2030 (USD Million)
Fig. 100: Argentina
Fig. 101: Argentina market estimates and forecast, 2018-2030 (USD Million)
Fig. 102: Middle East & Africa
Fig. 103: MEA market estimates and forecast, 2018-2030 (USD Million)
Fig. 104: South Africa
Fig. 105: South Africa market estimates and forecast, 2018-2030 (USD Million)
Fig. 106: Saudi Arabia
Fig. 107: Saudi Arabia market estimates and forecast, 2018-2030 (USD Million)
Fig. 108: UAE
Fig. 109: UAE market estimates and forecast, 2018-2030 (USD Million)
Fig. 110: Kuwait
Fig. 111: Kuwait market estimates and forecast, 2018-2030 (USD Million)
Fig. 2: Market research process
Fig. 3: Data triangulation techniques
Fig. 4: Primary research pattern
Fig. 5: Market research approaches
Fig. 6: Value-chain-based sizing & forecasting
Fig. 7: QFD modeling for market share assessment
Fig. 8: Market formulation & validation
Fig. 9: Real-time PCR (qPCR), end point PCR, and dPCR market snapshot
Fig. 10: Parent market outlook
Fig. 11: Related/ancillary market outlook
Fig. 12: Penetration and growth prospect mapping
Fig. 13: Real-time PCR (qPCR), end point PCR, and dPCR market driver impact
Fig. 14: Real-time PCR (qPCR), end point PCR, and dPCR market restraint impact
Fig. 15: SWOT analysis, by factor (Political & legal, economic, and technological)
Fig. 16: Industry Analysis - Porter’s
Fig. 17: Strategy mapping
Fig. 18: Ansoff Matrix
Fig. 19: Competitive dashboard analysis
Fig. 20: Regional network map
Fig. 21: Real-time PCR (qPCR), end point PCR, and dPCR market: Technology outlook and key takeaways
Fig. 22: Real-time PCR (qPCR), end point PCR, and dPCR market: Technology movement analysis& market share 2022 & 2030
Fig. 23: Quantitative market estimates and forecast, 2018-2030(USD Million)
Fig. 24: Digital market estimates and forecast, 2018-2030 (USD Million)
Fig. 25: End-point PCR market estimates and forecast, 2018-2030(USD Million)
Fig. 26: Real-time PCR (qPCR), end point PCR, and dPCR market: Products outlook and key takeaways
Fig. 27: Real-time PCR (qPCR), end point PCR, and dPCR market: Products movement analysis & market share 2022 & 2030
Fig. 28: Consumables & reagents market estimates and forecast, 2018-2030 (USD Million)
Fig. 29: Instruments market estimates and forecast, 2018-2030 (USD Million)
Fig. 30: Software & services market estimates and forecast, 2018-2030 (USD Million)
Fig. 31: Real-time PCR (qPCR), end point PCR, and dPCR market: Application outlook and key takeaways
Fig. 32: Real-time PCR (qPCR), end point PCR, and dPCR market: Application movement analysis & market share 2022 & 2030
Fig. 33: Clinical market estimates and forecast, 2018-2030 (USD Million)
Fig. 34: Pathogen testing market estimates and forecast, 2018-2030 (USD Million)
Fig. 35: Oncology testing market estimates and forecast, 2018-2030 (USD Million)
Fig. 36: Blood screening market estimates and forecast, 2018-2030 (USD Million)
Fig. 37: Liquid Biopsy testing market estimates and forecast, 2018-2030 (USD Million)
Fig. 38: dPCR-based Non-Invasive Prenatal Testing (NIPT) market estimates and forecast, 2018-2030 (USD Million)
Fig. 39: Others market estimates and forecast, 2018-2030 (USD Million)
Fig. 40: Research market estimates and forecast, 2018-2030 (USD Million)
Fig. 41: Stem cell research market estimates and forecast, 2018-2030 (USD Million)
Fig. 42: DNA cloning & sequencing market estimates and forecast, 2018-2030 (USD Million)
Fig. 43: Recombinant DNA technology market estimates and forecast, 2018-2030 (USD Million)
Fig. 44: Rare mutation detection market estimates and forecast, 2018-2030 (USD Million)
Fig. 45: Gene expression market estimates and forecast, 2018-2030 (USD Million)
Fig. 46: Single-cell analysis market estimates and forecast, 2018-2030 (USD Million)
Fig. 47: Microbiome analysis market estimates and forecast, 2018-2030 (USD Million)
Fig. 48: Copy number variation analysis market estimates and forecast, 2018-2030 (USD Million)
Fig. 49: Library quantification (NGS) market estimates and forecast, 2018-2030 (USD Million)
Fig. 50: Characterization of low-fold changes in mRNA and miRNA expression market estimates and forecast, 2018-2030 (USD Million)
Fig. 51: Species identification market estimates and forecast, 2018-2030 (USD Million)
Fig. 52: GMO detection market estimates and forecast, 2018-2030 (USD Million)
Fig. 53: Forensics and others market estimates and forecast, 2018-2030 (USD Million)
Fig. 54: Real-time PCR (qPCR), end point PCR, and dPCR market: Regional outlook and key takeaways
Fig. 55: Regional outlook, 2022 & 2030
Fig. 56: North America
Fig. 57: North America. market estimates and forecast, 2018-2030 (USD Million)
Fig. 58: U.S.
Fig. 59: U.S. market estimates and forecast, 2018-2030 (USD Million)
Fig. 60: Canada
Fig. 61: Canada market estimates and forecast, 2018-2030 (USD Million)
Fig. 62: Europe
Fig. 63: Europe market estimates and forecast, 2018-2030 (USD Million)
Fig. 64: UK
Fig. 65: UK market estimates and forecast, 2018-2030 (USD Million)
Fig. 66: Germany
Fig. 67: Germany market estimates and forecast, 2018-2030 (USD Million)
Fig. 68: France
Fig. 69: France market estimates and forecast, 2018-2030 (USD Million)
Fig. 70: Italy
Fig. 71: Italy market estimates and forecast, 2018-2030 (USD Million)
Fig. 72: Spain
Fig. 73: Spain market estimates and forecast, 2018-2030 (USD Million)
Fig. 74: Denmark
Fig. 75: Denmark market estimates and forecast, 2018-2030 (USD Million)
Fig. 76: Sweden
Fig. 77: Sweden market estimates and forecast, 2018-2030 (USD Million)
Fig. 78: Norway
Fig. 79: Norway market estimates and forecast, 2018-2030 (USD Million)
Fig. 80: Asia-Pacific
Fig. 81: Asia-Pacific market estimates and forecast, 2018-2030 (USD Million)
Fig. 82: Japan
Fig. 83: Japan market estimates and forecast, 2018-2030(USD Million)
Fig. 84: India
Fig. 85: India. market estimates and forecast, 2018-2030 (USD Million)
Fig. 86: China
Fig. 87: China market estimates and forecast, 2018-2030 (USD Million)
Fig. 88: Australia
Fig. 89: Australia market estimates and forecast, 2018-2030 (USD Million)
Fig. 90: South Korea
Fig. 91: South Korea market estimates and forecast, 2018-2030 (USD Million)
Fig. 92: Thailand
Fig. 93: Thailand market estimates and forecast, 2018-2030 (USD Million)
Fig. 94: Latin America
Fig. 95: Latin America. market estimates and forecast, 2018-2030 (USD Million)
Fig. 96: Brazil
Fig. 97: Brazil market estimates and forecast, 2018-2030 (USD Million)
Fig. 98: Mexico
Fig. 99: Mexico market estimates and forecast, 2018-2030 (USD Million)
Fig. 100: Argentina
Fig. 101: Argentina market estimates and forecast, 2018-2030 (USD Million)
Fig. 102: Middle East & Africa
Fig. 103: MEA market estimates and forecast, 2018-2030 (USD Million)
Fig. 104: South Africa
Fig. 105: South Africa market estimates and forecast, 2018-2030 (USD Million)
Fig. 106: Saudi Arabia
Fig. 107: Saudi Arabia market estimates and forecast, 2018-2030 (USD Million)
Fig. 108: UAE
Fig. 109: UAE market estimates and forecast, 2018-2030 (USD Million)
Fig. 110: Kuwait
Fig. 111: Kuwait market estimates and forecast, 2018-2030 (USD Million)
Companies Mentioned
- Abbott
- Qiagen
- Bio-Rad Laboratories Inc.
- Agilent Technologies, Inc.
- Thermo Fisher Scientific, Inc.
- Cytiva (GE HEALTHCARE)
- BIOMÉRIEUX SA
- F. Hoffmann-La Roche Ltd
- Fluidigm Corporation
- Stilla
- Microsynth Ag
- Jn Medsys
- Danaher
Methodology
LOADING...
